Unfractionated and low-molecular-weight heparin for hypercoagulability in dogs and cats - Veterinary Medicine
  • SEARCH:
Medicine Center
DVM Veterinary Medicine Featuring Information from:

ADVERTISEMENT

Unfractionated and low-molecular-weight heparin for hypercoagulability in dogs and cats
A new type of heparin, low-molecular-weight heparin, shows promise as an effective and easier-to-use form of therapy for people prone to thromboembolism. Does the same hold true for dogs and cats?


VETERINARY MEDICINE


50. Lunsford K, Mackin A, Langston C, et al. Pharmacokinetics of the biological effects of subcutaneous enoxaparin in dogs (abst). J Vet Intern Med 2005;19:400.

51. Lauer MA, Houghtaling PL, Peterson JG, et al. Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. Circulation 2001;104:2772-2777.

52. McMichael M. Primary hemostasis. J Vet Emerg Crit Care 2005;15:1-8.

53. Jang I-K, Hursting MJ. When heparins promote thrombosis: review of heparin-induced thrombocytopenia. Circulation 2005;111:2671-2683.

54. Abrams-Ogg, A, Mathews, KA. Acute immune-mediated hemolytic anemia in dogs. In: Mathews KA. Veterinary emergency and critical care manual. Guelph, Ontario: Lifelearn, 2006;411-415.


ADVERTISEMENT

Source: VETERINARY MEDICINE,
Click here